Bio-Rad (BIO) Shares Tumble as Credit Agricole Downgrades from Outperform to Underperform
Get Alerts BIO Hot Sheet
Price: $355.23 -0.29%
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Shares of Bio-Rad Labs (NYSE: BIO) have sunk midday Tuesday following an intraday downgrade from Credit Agricole's Paul Knight. The stock is now down 0.8 percent to $102.25.
Knight now rates Bio-Rad shares an Underperform, down from Outperform previously. The analyst cut his price target on the stock from $110 to $108.
For an analyst ratings summary and ratings history on Bio-Rad Labs click here. For more ratings news on Bio-Rad Labs click here.
Knight now rates Bio-Rad shares an Underperform, down from Outperform previously. The analyst cut his price target on the stock from $110 to $108.
For an analyst ratings summary and ratings history on Bio-Rad Labs click here. For more ratings news on Bio-Rad Labs click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Maxim Group Upgrades Co-Diagnostics (CODX) to Buy
- JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
Credit AgricoleSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share